Search clinical trials for: Noritate® 1% cream

Total 995 results

French Innovative Leukemia Organisation

Completed

Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas

Diffuse Large B-Cell Lymphoma

France
The University of Texas Health Science Center at...

Terminated

AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer

Urinary Bladder Neoplasms

United States
Swiss Group for Clinical Cancer Research
Nordic Lymphoma Group

Terminated

Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma

Follicular Lymphoma

Sweden, Finland, Denmark, Norway, Switzerland, Austria
Charite University, Berlin, Germany
NeuroCure Clinical Research Center, Charite, Berlin

Terminated

MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study) (MOVING)

Multiple Sclerosis

Germany
Boehringer Ingelheim

Completed

Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers

Healthy
University Hospital, Montpellier

Completed

Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study (ENTRESTO696)

Chronic Heart Failure | Sleep Apnea Syndrome

France
InflaRx GmbH
Merck Sharp & Dohme LLC

Active, not recruiting

Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.

SCC - Squamous Cell Carcinoma of Skin

United States, Spain, Germany, Belgium, France
Eli Lilly and Company
Locemia Solutions ULC

Completed

Evaluate the Immunogenicity of a Novel Glucagon Formulation

Diabetes Mellitus | Drug-specific Antibodies

Canada
Gilead Sciences

Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen

Hepatitis C Virus Infection

United States
Boehringer Ingelheim

Completed

Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure

Hypertension
Boehringer Ingelheim

Completed

Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension

Hypertension
Boehringer Ingelheim

Completed

Pharmacovigilance and Patient Compliance in Hypertensive Patients

Hypertension
Alcon Research

Completed

Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration (RACE)

Exudative Age-Related Macular Degeneration

United States
Oregon Health and Science University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

Regulation of Cortisol Metabolism and Fat Patterning

Obesity | Menopausal Syndrome

United States
Food and Drug Administration (FDA)
Spaulding Clinical Research LLC

Completed

Assessment of the Human Systemic Absorption of Sunscreen Ingredients

Systemic Exposure to Sunscreen Ingredients

United States
Synedgen, Inc.
Louisiana State University Health Sciences Center in New Orleans

Recruiting

SWC for Treatment of Superficial Partial-Thickness Burns

Burn Wounds

United States
University of Virginia

Unknown

Umbilical Cord Care for the Prevention of Colonization

Central Line-associated Bloodstream Infection (CLABSI) | Line Insertion Site

United States
Labrha
Statitec

Recruiting

Safety of Use and Efficacy of Pandora for Patients Suffering From Gonarthrosis (PANDORA2) (PANDORA2)

Knee Osteoarthritis

France, Monaco
Bristol-Myers Squibb

Recruiting

A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis (COLIBRI)

Colitis, Ulcerative

Germany
Peking University People's Hospital

Completed

Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China

Upper Respiratory Tract Infection | Skin Infection | Lower Respiratory Infection | Genital Infection | Subcutaneous Tissues Infection

China
Boehringer Ingelheim

Completed

Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

Hypertension
Boehringer Ingelheim

Completed

A Study in Healthy Men to Find the Best Formulation for Once Daily Intake of Nintedanib

Healthy

United Kingdom
Teva Pharmaceuticals USA

Completed

Granisetron 1 mg Tablets, Non-fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Granisetron 1 mg Tablets Under Fasting Conditions

Healthy

Canada
Mylan Inc.
DPT Laboratories, Ltd.

Completed

Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis

Tinea Pedis
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (MEQ00064)

Healthy Volunteers | Meningococcal Immunisation

South Africa, India
FPR Specialty Pharmacy

Unknown

Treatment of Knee Pain With Topical Diclofenac Cream 8% or Diclofenac Gel 1%

Knee Injuries | Knee Pain Chronic

United States
EMS

Withdrawn

Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.

Hypertension | Dyslipidemia
Galderma R&D

Completed

Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo

Rosacea

United States
Takeda

Completed

International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

Hypertension

Russian Federation, Kazakhstan
Takeda

Completed

Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia

Type 2 Diabetes Mellitus | Essential Hypertension

Taiwan, Thailand, China
University of Washington
National Institute of Mental Health (NIMH); Public Health - Seattle and King...

Completed

Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)

HIV

United States
Boehringer Ingelheim

Completed

Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

Hypertension
Actelion

Completed

Two Period / Two Treatment Cross-over to Assess the Effect of Florastor® on Gastrointestinal Tolerability, Safety, and PK in Healthy Subjects Receiving Zavesca®

Diarrhea

Canada
Abbott Medical Optics

Completed

Clinical Investigation of the Next-Generation Intraocular Lens

Cataract

United States
GlaxoSmithKline

Completed

DUAC® Early Onset Efficacy Study in Japanese Subjects

Acne Vulgaris

Japan
Takeda

Completed

Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.

Heart Failure

Germany
M.D. Anderson Cancer Center
Amgen

Recruiting

A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation

Lung Cancer

United States
University of Oxford
National Institute of Allergy and Infectious Diseases (NIAID); Wellcome Trust

Completed

A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo

Ebola | Ebola Zaire

United Kingdom
ANRS, Emerging Infectious Diseases
ViiV Healthcare

Completed

A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)

HIV-1 Infection

France
Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

Gastric Neoplasms | Gastroesophageal Junction Adenocarcinoma

United States, Australia, Brazil, Chile, China, France, Germany, Guatemala, Ireland, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
Gilead Sciences

Completed

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United States, France, United Kingdom, Germany, Italy
Timothy Boone, MD, PhD
Astellas Pharma US, Inc.

Completed

Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms (LUTS)

Lower Urinary Tract Symptoms

United States
Taro Pharmaceuticals USA

Completed

Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis

Tinea Pedis

United States, Belize
Gilead Sciences

Completed

Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen

Hepatitis C Virus Infection

Japan
Hospital General "Dr. Miguel Silva" de Morelia
Universidad Nacional Autonoma de Mexico; NAUSLIFE HEMODIALYSIS CLINICS

Unknown

Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients (BICATH)

End Stage Renal Disease | Hemodialysis Access Failure | Vascular Access Complication | Catheter Complications | Hemodialysis Catheter Infection

Mexico
University of Southern California
United States Department of Defense

Completed

Oral Contraceptive (OC) Progestin Dose and Breast Proliferation

Oral Contraceptive

United States
Boehringer Ingelheim

Completed

Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride in Healthy Male Subjects

Healthy
Boehringer Ingelheim

Completed

FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Grifols Therapeutics LLC

Recruiting

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

Alpha1-Antitrypsin Deficiency

United States

3

Subscribe